These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3080379)

  • 21. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Labetalol infusion in hypertensive emergencies.
    Lebel M; Langlois S; Belleau LJ; Grose JH
    Clin Pharmacol Ther; 1985 Jun; 37(6):615-8. PubMed ID: 3891186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined alpha- and beta-blockade with labetalol in post-open heart surgery hypertension. Reversal of hemodynamic deterioration with glucagon.
    Meretoja OA; Allonen H; Arola M; Laaksonen VO
    Chest; 1980 Dec; 78(6):810-5. PubMed ID: 7004797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
    Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
    Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenergic activity in systolic hypertension.
    Agabiti-Rosei E; Alicandri C; Fariello R; Beschi M; Boni E; Castellano M; Muiesan ML; Romanelli G; Muiesan G
    Clin Exp Hypertens A; 1982; 4(7):1085-96. PubMed ID: 7116659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients.
    Townsend RR; DiPette DJ; Goodman R; Blumfield D; Cronin R; Gradman A; Katz LA; McCarthy EP; Sopko G
    Clin Pharmacol Ther; 1990 Dec; 48(6):665-75. PubMed ID: 2249378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood gas and hemodynamic changes induced by the treatment of pulmonary congestion with vasodilators in the acute phase of myocardial infarction.
    Renard M; Verhoeven A; Liebens I; Bernard R
    Acta Cardiol; 1986; 41(2):111-21. PubMed ID: 3087125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. I.v. labetalol in the treatment of hypertension following coronary-artery surgery.
    Morel DR; Forster A; Suter PM
    Br J Anaesth; 1982 Nov; 54(11):1191-6. PubMed ID: 7138722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central inhibition of sympathetic overdrive by clonidine in acute myocardial infarction with systolic hypertension. Haemodynamic study.
    Renard M; Liebens I; Waterschoot P; Bernard R
    Angiology; 1986 Sep; 37(9):633-41. PubMed ID: 3767070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phentolamine for vasodilator therapy in left ventricular failure complicating acute myocardial infarction. Haemodynamic study.
    Perret Cl; Gardaz JP; Reynaert M; Grimbert F; Enrico JF
    Br Heart J; 1975 Jun; 37(6):640-6. PubMed ID: 1148063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous labetalol versus sodium nitroprusside for treatment of hypertension postcoronary bypass surgery.
    Cruise CJ; Skrobik Y; Webster RE; Marquez-Julio A; David TE
    Anesthesiology; 1989 Dec; 71(6):835-9. PubMed ID: 2686494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
    Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
    Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of systolic time intervals in the evaluation of antihypertensive treatment with metoprolol, labetalol and prazosin.
    Buch J; Rasmussen S
    Cor Vasa; 1983; 25(5):358-66. PubMed ID: 6653128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Labetalol infusion for the treatment of hypertension in acute myocardial infarction.
    Timmis AD; Fowler MB; Jaggarao NS; Chamberlain DA
    Eur Heart J; 1980 Dec; 1(6):413-6. PubMed ID: 7274255
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension].
    Smirnov GB
    Kardiologiia; 1986 Mar; 26(3):33-6. PubMed ID: 2872358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central haemodynamic effects of metoprolol early in acute myocardial infarction. A placebo controlled randomized study of patients with low heart rate.
    Held PH; Hjalmarson A; Rydén L; Swedberg K
    Eur Heart J; 1986 Nov; 7(11):937-44. PubMed ID: 3539618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intravenous metoprolol on left ventricular performance in Q-wave acute myocardial infarction.
    Dell'Italia LJ; Walsh RA
    Am J Cardiol; 1989 Jan; 63(3):166-71. PubMed ID: 2909996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
    Mehta J; Feldman RL; Marx JD; Kelly GA
    Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.